VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISHL12 2022 | The importance of assessing cardiac risk in patients undergoing treatment for HL

Jenica Upshaw, MD, Tufts University, Boston, MA, shares some insights into the importance of assessing cardiac risk factors in patients with Hodgkin lymphoma (HL) undergoing treatment, highlighting the importance of evaluating symptoms and conducting post-treatment echocardiograms. This interview took place at The 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter